speb/financial-data huggingface dataset:
BHF balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 87375000000.00
BHF cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -26000000.00
BHF cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 226000000.00
BHF cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -485000000.00
BHF cash_flow (quarterly, 2026-03-31) — Changes In Cash: -480000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5563000000.00
BHF cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
BHF income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 57735327.00
BHF income_statement (quarterly, 2026-03-31) — Diluted EPS: -13.79
BHF income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -792000000.00
BHF income_statement (quarterly, 2026-03-31) — EBIT: -948000000.00
BHF cash_flow (quarterly, 2026-03-31) — End Cash Position: 4907000000.00
BHF cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 226000000.00
BHF cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -221000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -4156000000.00
BHF income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 191000000.00
BHF cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 4000000.00
BHF income_statement (quarterly, 2026-03-31) — Interest Expense: 38000000.00
BHF income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 38000000.00
BHF cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 6000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8717000000.00
BHF cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -485000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 87761000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 4673000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 3154000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3154000000.00
BHF cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 4673000000.00
BHF income_statement (quarterly, 2026-03-31) — Loss Adjustment Expense: 1385000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Minority Interest: 65000000.00
BHF income_statement (quarterly, 2026-03-31) — Minority Interests: -2000000.00
BHF cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 25000000.00
BHF cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
BHF income_statement (quarterly, 2026-03-31) — Net Income: -766000000.00
BHF income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -792000000.00
BHF income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -764000000.00
BHF income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -766000000.00
BHF income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -766000000.00
BHF income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -764000000.00
BHF income_statement (quarterly, 2026-03-31) — Net Interest Income: -38000000.00
BHF cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -662000000.00
BHF cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1000000.00
BHF cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1000000.00
BHF income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -38000000.00
BHF cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 297000000.00
BHF income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 1385000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5563000000.00
BHF income_statement (quarterly, 2026-03-31) — Normalized Income: -766000000.00
BHF cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -221000000.00
BHF income_statement (quarterly, 2026-03-31) — Operating Revenue: 1460000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 57437709.00
BHF balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -4156000000.00
BHF income_statement (quarterly, 2026-03-31) — Other Income Expense: 129000000.00
BHF income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 168000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 82468000000.00
BHF income_statement (quarterly, 2026-03-31) — Policyholder Benefits Gross: 1385000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 70100000.00
BHF balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
BHF cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -26000000.00
BHF income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 26000000.00
BHF income_statement (quarterly, 2026-03-31) — Pretax Income: -986000000.00
BHF cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -54000000.00
BHF cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -8868000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Receivables: 20842000000.00
BHF cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1000000.00
BHF cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
BHF balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1452000000.00
BHF income_statement (quarterly, 2026-03-31) — Salaries And Wages: 191000000.00
BHF cash_flow (quarterly, 2026-03-31) — Sale Of Business: 79000000.00
BHF cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 8206000000.00
BHF income_statement (quarterly, 2026-03-31) — Selling General And Administration: 191000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Share Issued: 124536688.00
BHF balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5563000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5563000000.00
BHF income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BHF income_statement (quarterly, 2026-03-31) — Tax Provision: -222000000.00
BHF income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
BHF balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 16000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Total Assets: 236803000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8717000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Total Debt: 3154000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5628000000.00
BHF income_statement (quarterly, 2026-03-31) — Total Expenses: 2446000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 231175000000.00
BHF balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 67098979.00
BHF balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 2699000000.00
BHFAM balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 530000000.00
BHFAM balance_sheet (annual, 2021-12-31) — Income Tax Payable: 62000000.00
BHFAM cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 339000000.00
BHFAM cash_flow (annual, 2021-12-31) — Issuance Of Debt: 400000000.00
BHFAM cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 400000000.00
BHFAM cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 339000000.00
BHFAM balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 1062000000.00
BHFAM balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 1062000000.00
BHFAM balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 530000000.00
BHFAM balance_sheet (annual, 2021-12-31) — Other Payable: 6269000000.00
BHFAM balance_sheet (annual, 2021-12-31) — Payables: 62000000.00
BHFAM balance_sheet (annual, 2021-12-31) — Payables And Accrued Expenses: 62000000.00
BHFAM cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 339000000.00
BHFAM income_statement (annual, 2021-12-31) — Total Other Finance Cost: 75000000.00
BHFAM balance_sheet (annual, 2021-12-31) — Total Tax Payable: 62000000.00
BHFAM income_statement (annual, 2022-12-31) — +Total Revenue: 6630000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Accounts Receivable: 18548000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 14075000000.00
BHFAM cash_flow (annual, 2022-12-31) — Amortization Of Securities: -233000000.00
BHFAM cash_flow (annual, 2022-12-31) — Beginning Cash Position: 4474000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Capital Stock: 1000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 4115000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 80773000000.00
BHFAM cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -104000000.00
BHFAM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 9145000000.00
BHFAM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -8276000000.00
BHFAM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -1228000000.00
BHFAM cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 1264000000.00
BHFAM cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 176000000.00
BHFAM cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -2539000000.00
BHFAM cash_flow (annual, 2022-12-31) — Change In Receivables: -1374000000.00
BHFAM cash_flow (annual, 2022-12-31) — Change In Working Capital: -4341000000.00
BHFAM cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -1374000000.00
BHFAM cash_flow (annual, 2022-12-31) — Changes In Cash: -359000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Common Stock: 1000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Common Stock Equity: 5533000000.00
BHFAM cash_flow (annual, 2022-12-31) — Common Stock Payments: -488000000.00
BHFAM income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 3775000000.00
BHFAM income_statement (annual, 2022-12-31) — EBIT: 4885000000.00
BHFAM cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 110000000.00
BHFAM cash_flow (annual, 2022-12-31) — End Cash Position: 4115000000.00
BHFAM cash_flow (annual, 2022-12-31) — Financing Cash Flow: 9145000000.00
BHFAM cash_flow (annual, 2022-12-31) — Free Cash Flow: -1228000000.00
BHFAM cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 248000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -6106000000.00
BHFAM income_statement (annual, 2022-12-31) — General And Administrative Expense: 647000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 459000000.00
BHFAM cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 44000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Income Tax Payable: 0.00
BHFAM income_statement (annual, 2022-12-31) — Interest Expense: 153000000.00
BHFAM income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 153000000.00
BHFAM cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 152000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Invested Capital: 8689000000.00
BHFAM cash_flow (annual, 2022-12-31) — Investing Cash Flow: -8276000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Investments And Advances: 81522000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 4775000000.00
BHFAM cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
BHFAM cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
BHFAM balance_sheet (annual, 2022-12-31) — Long Term Debt: 3156000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3156000000.00
BHFAM cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
BHFAM cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 4775000000.00
BHFAM income_statement (annual, 2022-12-31) — Loss Adjustment Expense: -1911000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Minority Interest: 65000000.00
BHFAM income_statement (annual, 2022-12-31) — Minority Interests: -5000000.00
BHFAM cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -562000000.00
BHFAM cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -488000000.00
BHFAM income_statement (annual, 2022-12-31) — Net Income: 3879000000.00
BHFAM income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 3775000000.00
BHFAM income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 3884000000.00
BHFAM income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 3879000000.00
BHFAM income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 3879000000.00
BHFAM cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 3884000000.00
BHFAM income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 3884000000.00
BHFAM income_statement (annual, 2022-12-31) — Net Interest Income: -153000000.00
BHFAM cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -4454000000.00
BHFAM cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -3000000.00
BHFAM cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -3000000.00
BHFAM income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -153000000.00
BHFAM cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 11449000000.00
BHFAM income_statement (annual, 2022-12-31) — Net Policyholder Benefits And Claims: -1911000000.00
BHFAM cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
BHFAM balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 5074000000.00
BHFAM income_statement (annual, 2022-12-31) — Normalized Income: 3879000000.00
BHFAM cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1228000000.00
BHFAM cash_flow (annual, 2022-12-31) — Operating Gains Losses: 358000000.00
BHFAM income_statement (annual, 2022-12-31) — Operating Revenue: 6630000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 68278068.00
BHFAM balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -6106000000.00
BHFAM income_statement (annual, 2022-12-31) — Other Income Expense: 478000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 459000000.00
BHFAM cash_flow (annual, 2022-12-31) — Other Non Cash Items: -2403000000.00
BHFAM income_statement (annual, 2022-12-31) — Other Operating Expenses: 878000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Other Payable: 4560000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 76658000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Payables: 4560000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 0.00
BHFAM income_statement (annual, 2022-12-31) — Policyholder Benefits Ceded: 1782000000.00
BHFAM income_statement (annual, 2022-12-31) — Policyholder Benefits Gross: -129000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 70100000.00
BHFAM balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
BHFAM cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -104000000.00
BHFAM income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 104000000.00
BHFAM cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
BHFAM income_statement (annual, 2022-12-31) — Pretax Income: 4732000000.00
BHFAM cash_flow (annual, 2022-12-31) — Purchase Of Business: -814000000.00
BHFAM cash_flow (annual, 2022-12-31) — Purchase Of Investment: -20487000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Receivables: 18586000000.00
BHFAM cash_flow (annual, 2022-12-31) — Repayment Of Debt: -3000000.00
BHFAM cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -488000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Retained Earnings: -395000000.00
BHFAM income_statement (annual, 2022-12-31) — Salaries And Wages: 647000000.00
BHFAM cash_flow (annual, 2022-12-31) — Sale Of Business: 252000000.00
BHFAM cash_flow (annual, 2022-12-31) — Sale Of Investment: 16033000000.00
BHFAM income_statement (annual, 2022-12-31) — Selling General And Administration: 647000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Share Issued: 122153422.00
BHFAM balance_sheet (annual, 2022-12-31) — Stockholders Equity: 5533000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Tangible Book Value: 5074000000.00
BHFAM income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BHFAM income_statement (annual, 2022-12-31) — Tax Provision: 848000000.00
BHFAM income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.18
BHFAM balance_sheet (annual, 2022-12-31) — Taxes Receivable: 38000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Total Assets: 224847000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Total Capitalization: 8689000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Total Debt: 3156000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 5598000000.00
BHFAM income_statement (annual, 2022-12-31) — Total Expenses: 1898000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 219249000000.00
BHFAM balance_sheet (annual, 2022-12-31) — Total Tax Payable: 0.00
BHFAM balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 53875354.00
BHFAM balance_sheet (annual, 2022-12-31) — Treasury Stock: 2042000000.00
BHFAM income_statement (annual, 2023-12-31) — +Total Revenue: 3950000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Accounts Receivable: 19761000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 14004000000.00
BHFAM cash_flow (annual, 2023-12-31) — Amortization Of Securities: -282000000.00
BHFAM cash_flow (annual, 2023-12-31) — Beginning Cash Position: 4115000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Capital Stock: 1000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 3851000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 86011000000.00
BHFAM cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -102000000.00
BHFAM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 3069000000.00
BHFAM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -3196000000.00
BHFAM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -137000000.00
BHFAM cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 1132000000.00
BHFAM cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 95000000.00
BHFAM cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1246000000.00
BHFAM cash_flow (annual, 2023-12-31) — Change In Receivables: -1280000000.00
BHFAM cash_flow (annual, 2023-12-31) — Change In Working Capital: -1252000000.00
BHFAM cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1280000000.00
BHFAM cash_flow (annual, 2023-12-31) — Changes In Cash: -264000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Common Stock: 1000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Common Stock Equity: 4943000000.00
BHFAM cash_flow (annual, 2023-12-31) — Common Stock Payments: -250000000.00
BHFAM income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -1214000000.00
BHFAM income_statement (annual, 2023-12-31) — EBIT: -1321000000.00
BHFAM cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 83000000.00
BHFAM cash_flow (annual, 2023-12-31) — End Cash Position: 3851000000.00
BHFAM cash_flow (annual, 2023-12-31) — Financing Cash Flow: 3069000000.00
BHFAM cash_flow (annual, 2023-12-31) — Free Cash Flow: -137000000.00
BHFAM cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 232000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -5246000000.00
BHFAM income_statement (annual, 2023-12-31) — General And Administrative Expense: 730000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 416000000.00
BHFAM cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 7000000.00
BHFAM income_statement (annual, 2023-12-31) — Interest Expense: 153000000.00
BHFAM income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 153000000.00
BHFAM cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 151000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Invested Capital: 8099000000.00
BHFAM cash_flow (annual, 2023-12-31) — Investing Cash Flow: -3196000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Investments And Advances: 87208000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 4946000000.00
BHFAM cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
BHFAM cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
BHFAM balance_sheet (annual, 2023-12-31) — Long Term Debt: 3156000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3156000000.00
BHFAM cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
BHFAM cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 4946000000.00
BHFAM income_statement (annual, 2023-12-31) — Loss Adjustment Expense: 1169000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Minority Interest: 65000000.00
BHFAM income_statement (annual, 2023-12-31) — Minority Interests: -5000000.00
BHFAM cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -248000000.00
BHFAM cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -250000000.00
BHFAM income_statement (annual, 2023-12-31) — Net Income: -1112000000.00
BHFAM income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -1214000000.00
BHFAM income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -1107000000.00
BHFAM income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -1112000000.00
BHFAM income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -1112000000.00
BHFAM cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -1107000000.00
BHFAM income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -1107000000.00
BHFAM income_statement (annual, 2023-12-31) — Net Interest Income: -153000000.00
BHFAM cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -3318000000.00
BHFAM cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -2000000.00
BHFAM cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -2000000.00
BHFAM income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -153000000.00
BHFAM cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 4313000000.00
BHFAM income_statement (annual, 2023-12-31) — Net Policyholder Benefits And Claims: 1169000000.00
BHFAM cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
BHFAM balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 4943000000.00
BHFAM income_statement (annual, 2023-12-31) — Normalized Income: -1112000000.00
BHFAM cash_flow (annual, 2023-12-31) — Operating Cash Flow: -137000000.00
BHFAM cash_flow (annual, 2023-12-31) — Operating Gains Losses: 315000000.00
BHFAM income_statement (annual, 2023-12-31) — Operating Revenue: 3950000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 63503355.00
BHFAM balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -5246000000.00
BHFAM income_statement (annual, 2023-12-31) — Other Income Expense: 483000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 416000000.00
BHFAM cash_flow (annual, 2023-12-31) — Other Non Cash Items: -2256000000.00
BHFAM income_statement (annual, 2023-12-31) — Other Operating Expenses: 728000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 82160000000.00
BHFAM income_statement (annual, 2023-12-31) — Policyholder Benefits Ceded: 1354000000.00
BHFAM income_statement (annual, 2023-12-31) — Policyholder Benefits Gross: 2523000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 70100000.00
BHFAM balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
BHFAM cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -102000000.00
BHFAM income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 102000000.00
BHFAM cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
BHFAM income_statement (annual, 2023-12-31) — Pretax Income: -1474000000.00
BHFAM cash_flow (annual, 2023-12-31) — Purchase Of Business: -453000000.00
BHFAM cash_flow (annual, 2023-12-31) — Purchase Of Investment: -14458000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Receivables: 19788000000.00
BHFAM cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2000000.00
BHFAM cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -250000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Retained Earnings: -1507000000.00
BHFAM income_statement (annual, 2023-12-31) — Salaries And Wages: 730000000.00
BHFAM cash_flow (annual, 2023-12-31) — Sale Of Business: 205000000.00
BHFAM cash_flow (annual, 2023-12-31) — Sale Of Investment: 11140000000.00
BHFAM income_statement (annual, 2023-12-31) — Selling General And Administration: 730000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Share Issued: 122818568.00
BHFAM balance_sheet (annual, 2023-12-31) — Stockholders Equity: 4943000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Tangible Book Value: 4943000000.00
BHFAM income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BHFAM income_statement (annual, 2023-12-31) — Tax Provision: -367000000.00
BHFAM income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.25
BHFAM balance_sheet (annual, 2023-12-31) — Taxes Receivable: 27000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Total Assets: 236340000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Total Capitalization: 8099000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Total Debt: 3156000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 5008000000.00
BHFAM income_statement (annual, 2023-12-31) — Total Expenses: 5424000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 231332000000.00
BHFAM balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 59315213.00
BHFAM balance_sheet (annual, 2023-12-31) — Treasury Stock: 2309000000.00
BHFAM cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
BHFAM income_statement (annual, 2024-12-31) — +Total Revenue: 4369000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Accounts Receivable: 21126000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 13927000000.00
BHFAM cash_flow (annual, 2024-12-31) — Amortization Of Securities: -330000000.00
BHFAM cash_flow (annual, 2024-12-31) — Beginning Cash Position: 3851000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Capital Stock: 1000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 5045000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 86968000000.00
BHFAM cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -102000000.00
BHFAM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 3678000000.00
BHFAM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -2194000000.00
BHFAM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -290000000.00
BHFAM cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1180000000.00
BHFAM cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 402000000.00
BHFAM cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -2043000000.00
BHFAM cash_flow (annual, 2024-12-31) — Change In Receivables: -1451000000.00
BHFAM cash_flow (annual, 2024-12-31) — Change In Working Capital: -2144000000.00
BHFAM cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -1451000000.00
BHFAM cash_flow (annual, 2024-12-31) — Changes In Cash: 1194000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Common Stock: 1000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Common Stock Equity: 4959000000.00
BHFAM cash_flow (annual, 2024-12-31) — Common Stock Payments: -250000000.00
BHFAM income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 286000000.00
BHFAM income_statement (annual, 2024-12-31) — EBIT: 574000000.00
BHFAM cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 41000000.00
BHFAM cash_flow (annual, 2024-12-31) — End Cash Position: 5045000000.00
BHFAM cash_flow (annual, 2024-12-31) — Financing Cash Flow: 3678000000.00
BHFAM cash_flow (annual, 2024-12-31) — Free Cash Flow: -290000000.00
BHFAM cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 264000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -5278000000.00
BHFAM income_statement (annual, 2024-12-31) — General And Administrative Expense: 693000000.00
BHFAM cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 13000000.00
BHFAM income_statement (annual, 2024-12-31) — Interest Expense: 152000000.00
BHFAM income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 152000000.00
BHFAM cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 151000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Invested Capital: 8114000000.00
BHFAM cash_flow (annual, 2024-12-31) — Investing Cash Flow: -2194000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Investments And Advances: 86827000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 4827000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Long Term Debt: 3155000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 3155000000.00
BHFAM cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 4827000000.00
BHFAM income_statement (annual, 2024-12-31) — Loss Adjustment Expense: -379000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Minority Interest: 65000000.00
BHFAM income_statement (annual, 2024-12-31) — Minority Interests: -5000000.00
BHFAM cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 38000000.00
BHFAM cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -250000000.00
BHFAM income_statement (annual, 2024-12-31) — Net Income: 388000000.00
BHFAM income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 286000000.00
BHFAM income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 393000000.00
BHFAM income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 388000000.00
BHFAM income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 388000000.00
BHFAM cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 393000000.00
BHFAM income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 393000000.00
BHFAM income_statement (annual, 2024-12-31) — Net Interest Income: -152000000.00
BHFAM cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -682000000.00
BHFAM cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -2000000.00
BHFAM cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -2000000.00
BHFAM cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -1000000.00
BHFAM income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -152000000.00
BHFAM cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 3811000000.00
BHFAM cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -4000000.00
BHFAM cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
BHFAM income_statement (annual, 2024-12-31) — Net Policyholder Benefits And Claims: -379000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 4959000000.00
BHFAM income_statement (annual, 2024-12-31) — Normalized Income: 388000000.00
BHFAM cash_flow (annual, 2024-12-31) — Operating Cash Flow: -290000000.00
BHFAM cash_flow (annual, 2024-12-31) — Operating Gains Losses: 305000000.00
BHFAM income_statement (annual, 2024-12-31) — Operating Revenue: 4369000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 58629049.00
BHFAM balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -5278000000.00
BHFAM income_statement (annual, 2024-12-31) — Other Income Expense: 579000000.00
BHFAM cash_flow (annual, 2024-12-31) — Other Non Cash Items: -2086000000.00
BHFAM income_statement (annual, 2024-12-31) — Other Operating Expenses: 736000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 81923000000.00
BHFAM income_statement (annual, 2024-12-31) — Policyholder Benefits Ceded: 1745000000.00
BHFAM income_statement (annual, 2024-12-31) — Policyholder Benefits Gross: 1366000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 70100000.00
BHFAM balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
BHFAM cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -102000000.00
BHFAM income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 102000000.00
BHFAM income_statement (annual, 2024-12-31) — Pretax Income: 422000000.00
BHFAM cash_flow (annual, 2024-12-31) — Purchase Of Business: -299000000.00
BHFAM cash_flow (annual, 2024-12-31) — Purchase Of Investment: -24917000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Receivables: 21145000000.00
BHFAM cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2000000.00
BHFAM cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -250000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Retained Earnings: -1119000000.00
BHFAM income_statement (annual, 2024-12-31) — Salaries And Wages: 693000000.00
BHFAM cash_flow (annual, 2024-12-31) — Sale Of Business: 337000000.00
BHFAM cash_flow (annual, 2024-12-31) — Sale Of Investment: 24235000000.00
BHFAM income_statement (annual, 2024-12-31) — Selling General And Administration: 693000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Share Issued: 123480326.00
BHFAM balance_sheet (annual, 2024-12-31) — Stockholders Equity: 4959000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Tangible Book Value: 4959000000.00
BHFAM income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BHFAM income_statement (annual, 2024-12-31) — Tax Provision: 29000000.00
BHFAM income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.07
BHFAM balance_sheet (annual, 2024-12-31) — Taxes Receivable: 19000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Total Assets: 238537000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Total Capitalization: 8114000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Total Debt: 3155000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 5024000000.00
BHFAM income_statement (annual, 2024-12-31) — Total Expenses: 3947000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 233513000000.00
BHFAM balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 64851277.00
BHFAM balance_sheet (annual, 2024-12-31) — Treasury Stock: 2572000000.00
BHFAM income_statement (quarterly, 2025-03-31) — +Total Revenue: 2320000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 21188000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 13939000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 5045000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4667000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 86876000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -26000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1087000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 563000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Changes In Cash: -378000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Common Stock: 1000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5239000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -59000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -294000000.00
BHFAM income_statement (quarterly, 2025-03-31) — EBIT: -316000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — End Cash Position: 4667000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1087000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 146000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -4670000000.00
BHFAM income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 202000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 7000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Interest Expense: 38000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 38000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 6000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Invested Capital: 8394000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 563000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 87486000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 4839000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 3155000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3155000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 4839000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Loss Adjustment Expense: 1542000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Minority Interest: 65000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Minority Interests: -2000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 22000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -59000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Net Income: -268000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -294000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -266000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -268000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -268000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -266000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Net Interest Income: -38000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -133000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
BHFAM income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -38000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1015000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 1542000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5239000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Normalized Income: -268000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 146000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Operating Revenue: 2320000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 57868389.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -4670000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Other Income Expense: 136000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 170000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 82209000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Policyholder Benefits Gross: 1542000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 70100000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
BHFAM cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -26000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 26000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Pretax Income: -354000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -65000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -6957000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Receivables: 21208000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
BHFAM cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -59000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1387000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Salaries And Wages: 202000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Sale Of Business: 87000000.00
BHFAM cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 6824000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Selling General And Administration: 202000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Share Issued: 123983633.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5239000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5239000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BHFAM income_statement (quarterly, 2025-03-31) — Tax Provision: -88000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
BHFAM balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 20000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Total Assets: 234681000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 8394000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Total Debt: 3155000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5304000000.00
BHFAM income_statement (quarterly, 2025-03-31) — Total Expenses: 2674000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 229377000000.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 66115244.00
BHFAM balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 2644000000.00
BHFAM income_statement (quarterly, 2025-06-30) — +Total Revenue: 790000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 21258000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 13918000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 4667000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 5540000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 87545000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -25000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 762000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 112000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Changes In Cash: 873000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Common Stock: 1000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 5673000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -43000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 60000000.00
BHFAM income_statement (quarterly, 2025-06-30) — EBIT: 131000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — End Cash Position: 5540000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 762000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -4257000000.00
BHFAM income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 179000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 3000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Interest Expense: 38000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 38000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 69000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Invested Capital: 8828000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 112000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 87397000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 4798000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 3155000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3155000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 4798000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Loss Adjustment Expense: -390000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Minority Interest: 65000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
BHFAM cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 56000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -43000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Net Income: 85000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 60000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 85000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 85000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 85000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 85000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Net Interest Income: -38000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -102000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -38000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 741000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: -390000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 5673000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Normalized Income: 85000000.00
BHFAM cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Operating Revenue: 790000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 57122494.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -4257000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Other Income Expense: 143000000.00
BHFAM income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 185000000.00
BHFAM balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 82005000000.00